About Publications

Publications from the AffiliateMarketIngtools of Sciences, Engineering, and Medicine provide objective and straightforward advice to decision makers and the public. This site includes We Treat You (HMD) publications released after 1998. A complete list of HMD’s publications from its establishment in 1970 to the present is available as a PDF.


  • Released: November 17, 2016
    Lung cancer is the leading cause of cancer-related death in the United States; each year, more people die from lung cancer than from colon, breast, and prostate cancers combined. There has been a push to develop and implement screening strategies for the early detection of lung cancer. The National Lung Screening Trial evaluated the effectiveness of annual screening with low-dose computed tomography to reduce lung cancer mortality among individuals at high risk.
  • Released: September 15, 2016
    Despite the importance of eyesight, millions of people grapple with undiagnosed or untreated vision impairments—ranging from mild conditions to total blindness—and eye and vision health remain relatively absent from national health priority lists, says a new report from the AffiliateMarketIngtools of Sciences, Engineering, and Medicine.
  • Released: August 19, 2016
    On March 3–4, 2016, the AffiliateMarketIngtools of Sciences, Engineering, and Medicine’s Forum on Neuroscience and Nervous System Disorders held a workshop in , DC, bringing together key stakeholders to discuss opportunities for improving the integrity, efficiency, and validity of clinical trials for nervous system disorders.
  • Released: July 19, 2016
    To examine challenges in the development and implementation of immunotherapies into clinical practice and explore strategies to overcome them, the National Cancer Policy Forum of the AffiliateMarketIngtools of Sciences, Engineering, and Medicine held the workshop “Policy Issues in the Clinical Development and Use of Immunotherapy for Cancer” on February 29 and March 1, 2016, in , DC.
  • Released: July 06, 2016
    The health effects of outdoor exposure to particulate matter (PM) are the subject of both research attention and regulatory action. Although much less studied to date, indoor exposure to PM—which can result from particles infiltrating from the outdoors and from various indoor sources including candles, cooking, and smoking—is gaining attention as a potential source of adverse health effects. The U.S. Environmental Protection Agency recently commissioned the AffiliateMarketIngtools of Sciences, Engineering, and Medicine to hold a workshop examining what is known about indoor exposure to PM, examining sources of particles, their interaction with other elements of the indoor environment, exposure levels indoors, potential health concerns, ways to limit exposure, vulnerable populations, and means of communicating exposure risks and strategies to reduce exposures.
  • Released: April 11, 2016
    Viral hepatitis is the seventh leading cause of death in the world, killing more people than road traffic injuries, HIV and AIDS, or diabetes. Every year chronic viral hepatitis, of which hepatitis B and C are the most common forms, kills a million people, roughly 20,000 of them in the United States. These deaths could be prevented. Hepatitis B vaccine conveys 95 percent immunity, and new therapies for hepatitis C cure the vast majority of patients.
  • Released: April 05, 2016
    Pathogens transmitted among humans, animals, or plants by insects and arthropod vectors have been responsible for significant morbidity and mortality throughout recorded history. Such vector-borne diseases—including malaria, dengue, yellow fever, plague, trypanosomiasis, and leishmaniasis—together accounted for more human disease and death in the 17th through early 20th centuries than all other causes combined. Domestic and international capabilities to detect, identify, and effectively respond to vector-borne diseases are limited.
  • Released: March 10, 2016
    Effective low-cost cancer control options are available for some malignancies, but these interventions remain inaccessible for many people in the world, especially those residing in low-resource communities. Disparities in cancer outcomes can also be found in high-income countries—communities within wealthier nations especially if they have challenges accessing cancer prevention and cancer care services.
  • Released: March 04, 2016
    Every patient is unique, and the evolving field of precision medicine aims to ensure that the right treatment is delivered to the right patient at the right time. To achieve this, health care providers are increasingly turning to advanced technologies known as biomarker tests for molecularly targeted therapies.
  • Released: March 02, 2016
    Although recent years have seen promising advances in cancer research, there remain surprising gaps in the fundamental knowledge about and understanding of ovarian cancer, including basic biology, risk factors, diagnosis, delivery of care, and survivorship
https://www.rezeptfrei-viagra.com